CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-07 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2022-01-07 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +27,000 | 27,000 | ||
| 2021-09-29 | HEALY JAMES Director | Sale | −286,076 | $16.12 | $4.6M | 0 |
| 2021-09-28 | HEALY JAMES Director | Sale | −48,329 | $17.17 | $830K | 286,076 |
| 2021-09-27 | HEALY JAMES Director | Sale | −100,150 | $18.06 | $1.8M | 334,405 |
| 2021-01-11 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-09-29 | HEALY JAMES Director | Other disposition | −950,000 | 0 | ||
| 2020-09-29 | HEALY JAMES Director | Other acquisition | +213,546 | 434,555 | ||
| 2020-08-28 | HEALY JAMES Director | Other disposition | −983,221 | 950,000 | ||
| 2020-08-28 | HEALY JAMES Director | Other acquisition | +221,009 | 221,009 | ||
| 2020-01-12 | HEALY JAMES Director | Option exercise | +20,000 | $12.37 | $247K | 70,086 |
| 2020-01-12 | HEALY JAMES Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2020-01-10 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-01-09 | HEALY JAMES Director | Option exercise | +29,994 | $1.67 | $50K | 30,086 |
| 2020-01-09 | HEALY JAMES Director | Option exercise | +20,000 | $10.05 | $201K | 50,086 |
| 2020-01-09 | HEALY JAMES Director | Option exercise · Stock Option (Right to Buy) | −29,994 | 0 | ||
| 2020-01-09 | HEALY JAMES Director | Option exercise · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2019-07-02 | HEALY JAMES Director | Sale | −160,000 | $22.61 | $3.6M | 1,933,221 |
| 2019-06-28 | HEALY JAMES Director | Sale | −200,000 | $22.05 | $4.4M | 2,093,221 |
| 2019-06-20 | HEALY JAMES Director | Sale | −317,130 | $21.37 | $6.8M | 2,293,221 |
Page 1 of 3 · 45 trades